Excel Bio Resources Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 15-11-2024
- Paid Up Capital ₹ 2.51 Cr
as on 15-11-2024
- Company Age 17 Year, 3 Days
- Last Filing with ROC 31 Mar 2024
- Revenue 13.96%
(FY 2023)
- Profit -3.25%
(FY 2023)
- Ebitda -2.76%
(FY 2023)
- Net Worth 3.54%
(FY 2023)
- Total Assets 3.30%
(FY 2023)
About Excel Bio Resources
The Corporate was formerly known as Excel Bio Resources Private Limited. The Company is engaged in the Machinery And Equipment Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 2.51 Cr, as per Ministry of Corporate Affairs (MCA) records.
Surendra Singhvi, Prakash Gagangras, Hrishit Shroff, and Two other members serve as directors at the Company.
- CIN/LLPIN
U01403MH2007PLC176907
- Company No.
176907
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
18 Dec 2007
- Date of AGM
05 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Excel Bio Resources?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Surendra Singhvi  | Director | 13-Feb-2024 | Current |
| Prakash Gagangras | Director | 13-Feb-2024 | Current |
| Hrishit Shroff | Director | 30-Jul-2015 | Current |
| Ravi Shroff | Director | 31-Aug-2016 | Current |
| Ashwin Shroff | Director | 22-Apr-2019 | Current |
Financial Performance and Corporate Structure Insights of Excel Bio Resources.
Excel Bio Resources Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 13.96% increase. The company also saw a slight decrease in profitability, with a 3.25% decrease in profit. The company's net worth moved up by a moderate rise of 3.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Excel Bio Resources?
In 2023, Excel Bio Resources had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Indian Centre For Climate And Societal Impacts ResearchActive 16 years 4 monthsAshwin Shroff is a mutual person
Excel Industries LimitedActive 64 years 3 monthsHrishit Shroff, Ravi Shroff and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Excel Bio Resources?
Unlock and access historical data on people associated with Excel Bio Resources, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Excel Bio Resources, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Excel Bio Resources's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
